Fondazione Gimema - Franco Mandelli Onlus

Fondazione Gimema - Franco Mandelli Onlus company information, Employees & Contact Information

La Fondazione GIMEMA (Gruppo Italiano Malattie EMatologiche dell’Adulto) Onlus promuove da oltre 30 anni la ricerca sulle leucemie e sulle altre malattie del sangue. Coordina un network nazionale a cui partecipa la quasi totalità dei centri ematologici italiani e gestisce numerose collaborazioni internazionali. Il Centro Dati, che ha sede a Roma ed è il cuore operativo della Fondazione, è una struttura di eccellenza, certificata e riconosciuta a livello internazionale per la sua attività di gestione delle sperimentazioni cliniche.

Company Details

Employees
57
Founded
-
Address
Via Casilina 5, Roma,00182,italy
Industry
Research Services
NAICS
Scientific Research and Development Services
Research and Development in the Physical, Engineering, and Life Sciences
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Website
gimema.org
HQ
Roma
Looking for a particular Fondazione Gimema - Franco Mandelli Onlus employee's phone or email?

Fondazione Gimema - Franco Mandelli Onlus Questions

News

GIMEMA SURVEY ON THE MANAGEMENT OF CHRONIC MYELOID LEUKEMIA PATIENTS IN THIRD LINE AND BEYOND: INSIGHTS FROM ITALIAN HEMATOLOGISTS - Frontiers

GIMEMA SURVEY ON THE MANAGEMENT OF CHRONIC MYELOID LEUKEMIA PATIENTS IN THIRD LINE AND BEYOND: INSIGHTS FROM ITALIAN HEMATOLOGISTS Frontiers

Real-world efficacy and safety of fostamatinib in ITP patients: Italian multicentre experience. GIMEMA ITP1122 study - Wiley Online Library

Real-world efficacy and safety of fostamatinib in ITP patients: Italian multicentre experience. GIMEMA ITP1122 study Wiley Online Library

Outcomes of allogeneic stem cell transplant in adult Philadelphia negative acute lymphoblastic leukemia patients treated with the pediatric-inspired GIMEMA 1913 protocol. A Campus ALL study | Bone Marrow Transplantation - Nature

Outcomes of allogeneic stem cell transplant in adult Philadelphia negative acute lymphoblastic leukemia patients treated with the pediatric-inspired GIMEMA 1913 protocol. A Campus ALL study | Bone Marrow Transplantation Nature

The prognostic value of health-related quality of life for early molecular response in patients with chronic myeloid leukemia: analysis of the GIMEMA-SUSTRENIM trial - Frontiers

The prognostic value of health-related quality of life for early molecular response in patients with chronic myeloid leukemia: analysis of the GIMEMA-SUSTRENIM trial Frontiers

Dasatinib–Blinatumomab for Ph-Positive Acute Lymphoblastic Leukemia in Adults - The New England Journal of Medicine

Dasatinib–Blinatumomab for Ph-Positive Acute Lymphoblastic Leukemia in Adults The New England Journal of Medicine

Long-Term Results of the Dasatinib-Blinatumomab Protocol for Adult Philadelphia-Positive ALL - ASCO Publications

Long-Term Results of the Dasatinib-Blinatumomab Protocol for Adult Philadelphia-Positive ALL ASCO Publications

GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia - ScienceDirect.com

GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia ScienceDirect.com

GIMEMA LALl2317: Sequential Chemotherapy and Blinatumomab for Adult ALL - OncLive

GIMEMA LALl2317: Sequential Chemotherapy and Blinatumomab for Adult ALL OncLive

Impact of induction regimen and allogeneic hematopoietic cell transplantation on outcome in younger adults with acute myeloid leukemia with a monosomal karyotype - Haematologica

Impact of induction regimen and allogeneic hematopoietic cell transplantation on outcome in younger adults with acute myeloid leukemia with a monosomal karyotype Haematologica

Up-front blinatumomab improves MRD clearance and outcome in adult Ph - ScienceDirect.com

Up-front blinatumomab improves MRD clearance and outcome in adult Ph ScienceDirect.com

Covid-19 in Philadelphia-negative myeloproliferative neoplasms: a GIMEMA survey on incidence, clinical management and vaccine - Nature

Covid-19 in Philadelphia-negative myeloproliferative neoplasms: a GIMEMA survey on incidence, clinical management and vaccine Nature

Physicians’ Perceptions of Clinical Utility of a Digital Health Tool for Electronic Patient-Reported Outcome Monitoring in Real-Life Hematology Practice. Evidence From the GIMEMA-ALLIANCE Platform - Frontiers

Physicians’ Perceptions of Clinical Utility of a Digital Health Tool for Electronic Patient-Reported Outcome Monitoring in Real-Life Hematology Practice. Evidence From the GIMEMA-ALLIANCE Platform Frontiers

Long-term results of the GIMEMA VEL-03-096 trial in MM patients receiving VTD consolidation after ASCT: MRD kinetics' impact on survival - Nature

Long-term results of the GIMEMA VEL-03-096 trial in MM patients receiving VTD consolidation after ASCT: MRD kinetics' impact on survival Nature

Targeted Therapy Alone for Acute Promyelocytic Leukemia - The New England Journal of Medicine

Targeted Therapy Alone for Acute Promyelocytic Leukemia The New England Journal of Medicine

Prognostic Factors for Overall Survival In Chronic Myeloid Leukemia Patients: A Multicentric Cohort Study by the Italian CML GIMEMA Network - Frontiers

Prognostic Factors for Overall Survival In Chronic Myeloid Leukemia Patients: A Multicentric Cohort Study by the Italian CML GIMEMA Network Frontiers

Decitabine in older patients with AML: quality of life results of the EORTC-GIMEMA-GMDS-SG randomized phase 3 trial - ScienceDirect.com

Decitabine in older patients with AML: quality of life results of the EORTC-GIMEMA-GMDS-SG randomized phase 3 trial ScienceDirect.com

Acute megakaryoblastic leukemia: experience of GIMEMA trials - Nature

Acute megakaryoblastic leukemia: experience of GIMEMA trials Nature

Bendamustine in combination with Ofatumumab in relapsed or refractory chronic lymphocytic leukemia: a GIMEMA Multicenter Phase II Trial - Nature

Bendamustine in combination with Ofatumumab in relapsed or refractory chronic lymphocytic leukemia: a GIMEMA Multicenter Phase II Trial Nature

TH2/TH1 Shift Under Ibrutinib Treatment in Chronic Lymphocytic Leukemia - Frontiers

TH2/TH1 Shift Under Ibrutinib Treatment in Chronic Lymphocytic Leukemia Frontiers

Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia - The New England Journal of Medicine

Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia The New England Journal of Medicine

Autologous or Allogeneic Bone Marrow Transplantation Compared with Intensive Chemotherapy in Acute Myelogenous Leukemia - The New England Journal of Medicine

Autologous or Allogeneic Bone Marrow Transplantation Compared with Intensive Chemotherapy in Acute Myelogenous Leukemia The New England Journal of Medicine

Cytoplasmic Nucleophosmin in Acute Myelogenous Leukemia with a Normal Karyotype - The New England Journal of Medicine

Cytoplasmic Nucleophosmin in Acute Myelogenous Leukemia with a Normal Karyotype The New England Journal of Medicine

GIMEMA-AIEOP AIDA protocol for the treatment of newly diagnosed acute - researchgate.net

GIMEMA-AIEOP AIDA protocol for the treatment of newly diagnosed acute researchgate.net

Levofloxacin to Prevent Bacterial Infection in Patients with Cancer and Neutropenia - The New England Journal of Medicine

Levofloxacin to Prevent Bacterial Infection in Patients with Cancer and Neutropenia The New England Journal of Medicine

Top Fondazione Gimema - Franco Mandelli Onlus Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant